Literature DB >> 26796360

Podoplanin-positive periarteriolar stromal cells promote megakaryocyte growth and proplatelet formation in mice by CLEC-2.

Shogo Tamura1, Katsue Suzuki-Inoue2, Nagaharu Tsukiji2, Toshiaki Shirai2, Tomoyuki Sasaki2, Makoto Osada3, Kaneo Satoh3, Yukio Ozaki2.   

Abstract

Megakaryopoiesis is the hierarchical differentiation of hematopoietic stem cells into megakaryocytes. Differentiating megakaryocytes undergo maturation characterized by endomitosis and produce numerous platelets through proplatelet formation. C-type lectin-like receptor 2 (CLEC-2) is a podoplanin (PDPN) receptor mainly expressed on platelets and megakaryocytes. Deletion of platelet/megakaryocyte CLEC-2 causes thrombocytopenia in mice; however, its contribution to megakaryopoiesis remains unknown. Here, we show that megakaryopoiesis is promoted through the CLEC-2/PDPN interaction in the vicinity of arterioles in the bone marrow (BM). We have also identified PDPN-expressing BM arteriolar stromal cells, tentatively termed as BM fibroblastic reticular cell (FRC)-like cells. Platelet/megakaryocyte-specific CLEC-2 conditional knockout (cKO) mice showed a decrease in the number of immature megakaryocytes. CLEC-2 wild-type megakaryocyte expansion was augmented in vitro by the addition of recombinant PDPN, but not cKO megakaryocytes. Moreover, megakaryocyte colonies were colocalized with periarteriolar BM FRC-like cells in the BM. Coculture of megakaryocytes with BM FRC-like cells augmented megakaryocyte expansion, which was dependent upon the CLEC-2/PDPN interaction. Furthermore, we found that the CLEC-2/PDPN interaction induces BM FRC-like cells to secrete chemokine (C-C motif) ligand 5 (CCL5) to facilitate proplatelet formation. These observations indicate that a reciprocal interaction between CLEC-2 on megakaryocytes and PDPN on BM FRC-like cells contributes to the periarteriolar megakaryopoietic microenvironment in mouse BM.
© 2016 by The American Society of Hematology.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26796360     DOI: 10.1182/blood-2015-08-663708

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  22 in total

1.  Cobalt hematoporphyrin inhibits CLEC-2-podoplanin interaction, tumor metastasis, and arterial/venous thrombosis in mice.

Authors:  Nagaharu Tsukiji; Makoto Osada; Tomoyuki Sasaki; Toshiaki Shirai; Kaneo Satoh; Osamu Inoue; Norihiko Umetani; Chihiro Mochizuki; Tamio Saito; Soichi Kojima; Hideyuki Shinmori; Yukio Ozaki; Katsue Suzuki-Inoue
Journal:  Blood Adv       Date:  2018-09-11

Review 2.  New Insights Into the Differentiation of Megakaryocytes From Hematopoietic Progenitors.

Authors:  Leila J Noetzli; Shauna L French; Kellie R Machlus
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-05-02       Impact factor: 8.311

3.  CLEC-2 and podoplanin, partners again.

Authors:  Jianxin Fu; Lijun Xia
Journal:  Blood       Date:  2016-03-31       Impact factor: 22.113

4.  A Role of the Podoplanin-CLEC-2 Axis in Promoting Inflammatory Response After Ischemic Stroke in Mice.

Authors:  Danyang Meng; Xiaohua Ma; Hui Li; Xuechun Wu; Yongjun Cao; Zhigang Miao; Xia Zhang
Journal:  Neurotox Res       Date:  2020-11-09       Impact factor: 3.911

5.  Periosteum-derived podoplanin-expressing stromal cells regulate nascent vascularization during epiphyseal marrow development.

Authors:  Shogo Tamura; Masato Mukaide; Yumi Katsuragi; Wataru Fujii; Koya Odaira; Nobuaki Suzuki; Nagaharu Tsukiji; Shuichi Okamoto; Atsuo Suzuki; Takeshi Kanematsu; Akira Katsumi; Akira Takagi; Katsuhide Ikeda; Jun Ueyama; Masaaki Hirayama; Katsue Suzuki-Inoue; Tadashi Matsushita; Tetsuhito Kojima; Fumihiko Hayakawa
Journal:  J Biol Chem       Date:  2022-03-15       Impact factor: 5.486

Review 6.  Platelets and platelet adhesion molecules: novel mechanisms of thrombosis and anti-thrombotic therapies.

Authors:  Xiaohong Ruby Xu; Naadiya Carrim; Miguel Antonio Dias Neves; Thomas McKeown; Tyler W Stratton; Rodrigo Matos Pinto Coelho; Xi Lei; Pingguo Chen; Jianhua Xu; Xiangrong Dai; Benjamin Xiaoyi Li; Heyu Ni
Journal:  Thromb J       Date:  2016-10-04

Review 7.  New horizon in platelet function: with special reference to a recently-found molecule, CLEC-2.

Authors:  Yukio Ozaki; Shogo Tamura; Katsue Suzuki-Inoue
Journal:  Thromb J       Date:  2016-10-04

Review 8.  The Role of CLEC-2 and Its Ligands in Thromboinflammation.

Authors:  Danyang Meng; Man Luo; Beibei Liu
Journal:  Front Immunol       Date:  2021-06-09       Impact factor: 7.561

Review 9.  Platelet-activating factor podoplanin: from discovery to drug development.

Authors:  Ai Takemoto; Kenichi Miyata; Naoya Fujita
Journal:  Cancer Metastasis Rev       Date:  2017-06       Impact factor: 9.264

Review 10.  Hematopoietic Stem Cell Regulation by Type I and II Interferons in the Pathogenesis of Acquired Aplastic Anemia.

Authors:  Julianne N P Smith; Vikramjit S Kanwar; Katherine C MacNamara
Journal:  Front Immunol       Date:  2016-08-29       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.